Switzerland · Investor

Roche Venture Fund

Last cheque observed Jun 2026; 57 cheques on record.

Email

Deploying nowCorporate VC

SeedSeries ABitcoinCryptocurrencyElectronics

Deploying now
100%of best year1cheques in 12 months, 57 on record
Since the last cheque135days00hrs00min00sec
Median round$50MRounds led1 of 57Exits7 from the portfolioMostly inUnited States, 73%
Pitch Roche Venture Fund

Roche Venture Fund highlights

  1. 01

    1 cheques in the last 12 months

  2. 02

    Mostly Series B and Series A: 58% of its rounds

  3. 03

    Led 1 rounds

  4. 04

    7 exits from the portfolio

What they do

Roche Venture Fund is mentioned as a listed name, but the homepage text does not describe its activities.From their own website
Type
Corporate VC (from a list, unverified)
Cheque size
From $3.0M as they say
Stages
SeedSeries A
Sectors
BitcoinCryptocurrencyElectronics
Based in
Basel, Switzerland
Cold pitches
Not stated

The record

Every round we can evidence, newest first57 appearances

  1. 2026

    1 round

  2. Jun
    COUR PharmaSeries B · US · Lumira Ventures$50MLed
  3. 2019

    2 rounds

  4. Jul
    FreenomeSeries B · US · FinSMEs$160MWith 11 others
  5. Jun
    Purigen BiosystemsSeries B · US · FinSMEs$26MWith 3 others
  6. 2016

    2 rounds

  7. Aug
    TiomaSeries A · US · FinSMEs$86MWith 2 others
  8. Jun
    OmiciaSeries B · US · Businesswire$23MWith 2 others
  9. 2015

    9 rounds

  10. Oct
    Minoryx TherapeuticsSeries A · ES$22MWith 6 others
  11. Sept
    AveXisSeries D · US$65MWith 11 others
  12. Jul
    SutroVaxSeries A · US$22MWith 3 others
  13. Jun
    Stratos GenomicsSeries B · US$15MWith 1 other
  14. Mar
    mySugrSeed · AT$4.8MWith 2 others
  15. Mar
    Macrolide PharmaceuticalsSeries A · US$22MWith 3 others
  16. Feb
    Lysosomal TherapeuticsSeries A · US$20MWith 6 others
  17. Jan
    AveXisSeries C · US$10MWith 1 other
  18. Jan
    CytomX TherapeuticsSeries C · US$20MWith 3 others
  19. 2014

    8 rounds

  20. Nov
    CuretisSeries B · DE$18MWith 6 others
  21. Oct
    Aileron TherapeuticsSeries E · US$33MWith 6 others
  22. Sept
    AllakosSeries A · US$10MWith 3 others
  23. Aug
    AllakosSeries A · US$25MWith 3 others
  24. Jul
    Epic SciencesSeries C · US$30MWith 4 others
  25. May
    Stratos GenomicsSeries B · US$10MWith 1 other
  26. May
    Lysosomal TherapeuticsSeed · US$4.8MWith 6 others
  27. Apr
    Alios BioPharmaSeries B · US$41MWith 3 others
  28. 2013

    8 rounds

  29. Nov
    MISSION TherapeuticsSeries B · GB · 4-traders.com$30MWith 3 others
  30. Nov
    Aileron TherapeuticsSeries E · US · finsmes.com$30MWith 5 others
  31. Oct
    BiodesySeries A · US · finsmes.com$15MWith 2 others
  32. Oct
    OpsonaSeries C · IE · finsmes.com$3.9MWith 8 others
  33. Jun
    Horizon DiscoverySeries C · GB · horizondiscovery.com$10MWith 11 others
  34. Apr
    OpsonaSeries C · IE · finsmes.com$43MWith 7 others
  35. Mar
    MacuLogixSeries A · US · prnewswire.com$3.6MWith 3 others
  36. Jan
    Aileron TherapeuticsSeries D · US · finsmes.com$12MWith 5 others
  37. 2012

    5 rounds

  38. Dec
    AllakosVenture · US · sec.gov$10.0MWith 4 others
  39. Nov
    Epic SciencesSeries B · US · finsmes.com$13MWith 2 others
  40. Nov
    Ambit BiosciencesVenture · US · phx.corporate-ir.net$50MWith 8 others
  41. Sept
    Foundation MedicineSeries B · US · finsmes.com$43MWith 6 others
  42. Jan
    Horizon DiscoverySeries C · GB · onbiovc.com$19MWith 3 others
  43. 2011

    4 rounds

  44. Oct
    CuretisSeries A · DE · curetis.com$13MWith 1 other
  45. Aug
    MISSION TherapeuticsVenture · GB · biospace.com$10MWith 3 others
  46. Jun
    Ambit BiosciencesSeries D · US · phx.corporate-ir.net$30MWith 9 others
  47. Feb
    Conatus PharmaceuticalsSeries B · US · pharmalive.com$20MWith 5 others
  48. 2010

    4 rounds

  49. Sept
    Horizon DiscoverySeries C · GB · fis.dowjones.com$9.8MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 45 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed7 in all

Foundation MedicineBought by RocheUndisclosedJan 2015
Alios BioPharmaBought by Johnson & Johnson$1.8BSept 2014
Ambit BiosciencesBought by Daiichi Sankyo$410MSept 2014
Foundation MedicineListed$108MJul 2013
Conatus PharmaceuticalsListed$69MJun 2013
HistoRxBought by GenoptixUndisclosedSept 2012
Intradigm CorporationBought by Silence TherapeuticsUndisclosedDec 2009

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Roche Venture Fund. A count of rooms they were both in, not a relationship either has claimed.

Novartis Venture FundCorporate VC15rounds togetherSR OneCorporate VC8rounds togetherAlta PartnersVC firm7rounds togetherForward VenturesAccelerator6rounds togetherNovo HoldingsVC firm6rounds togetherPfizerCorporate VC6rounds togetherGimvPrivate equity5rounds togetherApple Tree PartnersVC firm4rounds togetherAstellas Venture ManagementCorporate VC4rounds togetherEQT life sciencePrivate equity4rounds togetherExcel Venture ManagementVC firm4rounds togetherLilly VenturesCorporate VC4rounds together

Recently backed

The latest companies Roche Venture Fund put money into.

COUR Pharma$50M · Jun 2026Freenome$160M · Jul 2019Purigen Biosystems$26M · Jun 2019Omicia$23M · Jun 2016

Quick answers about Roche Venture Fund

What does Roche Venture Fund invest in?

Roche Venture Fund invests most often at Series B and Series A (58% of the rounds on record), in sectors such as Bitcoin, Cryptocurrency and Electronics.

How active is Roche Venture Fund?

57 investments on record, 1 of them in the last 12 months, and it led 1. The most recent was in Jun 2026.

What has Roche Venture Fund invested in recently?

Its most recent investments on record: COUR Pharma (Series B, Jun 2026), Freenome (Series B, Jul 2019) and Purigen Biosystems (Series B, Jun 2019).

How big are Roche Venture Fund's cheques?

The median round it joins is $50M.

Does Roche Venture Fund lead rounds?

Sometimes: it led 1 of its 57 investments on record (2%).

Where does Roche Venture Fund invest?

Most of the companies it backs are in the United States (73%), the United Kingdom (13%) and Germany (5%).

Is Roche Venture Fund investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

Who does Roche Venture Fund invest alongside?

Most often Novartis Venture Fund (15 rounds together), SR One (8 rounds together) and Alta Partners (7 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it